TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 8.54
-0.53 (-5.84%)
Oct 22, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 3.48 billion as of October 21, 2026. It is the 15,322nd most valuable company in the world and the 684th biggest in Hong Kong. Its market cap has decreased by 94.93% in one year.
Market Cap
3.48B
Enterprise Value
2.42B
Revenue
40.93M
Global Rank
Country Rank
#684 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since June 23, 2025, HKG:2617's market cap has decreased from 9.33B to 3.48B, a decrease of -62.71%. That is a compound annual growth rate of -52.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.48B | -92.37% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CK Life Sciences Int'l., (Holdings) | 4.90B |
| Jacobio Pharmaceuticals Group | 4.09B |
| Ocumension Therapeutics | 4.03B |
| Hanx Biopharmaceuticals (Wuhan) | 3.68B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.57B |
| Shanghai Bao Pharmaceuticals | 3.10B |
| Beijing Luzhu Biotechnology | 3.04B |